From the Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994.
D000998:Antiviral Agents / Q000627:therapeutic use; D017848:Blood-Borne Pathogens; D016022:Case-Control Studies; D005602:France / Q000453:epidemiology; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000635:transmission; D006679:HIV Seropositivity / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission*; D006282:Health Personnel / Q000706:statistics & numerical data*; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000706:statistics & numerical data*; D016602:Needlestick Injuries; D016273:Occupational Exposure; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine